2633 logo

Jacobson Pharma Corporation Limited Stock Price

SEHK:2633 Community·HK$2.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

2633 Share Price Performance

HK$1.05
-0.41 (-27.93%)
HK$1.05
-0.41 (-27.93%)
Price HK$1.05

2633 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record and pays a dividend.

1 Risk
4 Rewards

Jacobson Pharma Corporation Limited Key Details

HK$1.6b

Revenue

HK$891.6m

Cost of Revenue

HK$677.9m

Gross Profit

HK$376.3m

Other Expenses

HK$301.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.15
43.19%
19.22%
36.6%
View Full Analysis

About 2633

Founded
2016
Employees
1768
CEO
Kwong Yip Sum
WebsiteView website
www.jacobsonpharma.com

Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally. The company offers a portfolio of generic drugs for various therapeutic classes, such as cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatologicals, and anti-allergics in oral solid and liquid, external liquid, semi-solid, sterile, rectal, and specialized forms. It also provides management and treasury services. Jacobson Pharma Corporation Limited was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong.

Recent 2633 News & Updates

Analysis Article Jun 26

Jacobson Pharma Corporation Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shareholders might have noticed that Jacobson Pharma Corporation Limited ( HKG:2633 ) filed its annual result this time...

Recent updates

No updates